#USA #Sun Life #Wellesley #Medical Claims #health conditions

Unraveling the Complexity of High-Cost Medical Claims

Sun Life U.S. has released its annual report on high-cost claims and injectable drug trends, analyzing over 70,000 medical claims exceeding $3 million. This report highlights key factors contributing to substantial healthcare expenses, which include comorbid conditions, prolonged hospital stays, and expensive injectable drugs. The findings indicate a concerning rise in claims, with a 46% increase in such claims from 2022 to 2026, reflecting the growing complexity of health care costs in the country.

Key Findings of the Report

The 2023 Sun Life report showcases that secondary health conditions, especially those that co-occur with primary diagnoses, significantly drive up the expense of medical care. Among the top conditions leading to high-cost claims are orthopedic/musculoskeletal issues, premature births, and various cancers. While premature births and cancers have traditionally been at the forefront of these claims, the prominence of orthopedic conditions is a more recent development, highlighting advancements in medical treatments and how these conditions are now assessed on a more serious level.

Jennifer Collier, president of Health and Risk Solutions at Sun Life U.S., comments, "We have a real opportunity to help people achieve meaningful, improved health outcomes by prioritizing whole-person care." This approach recognizes that health conditions often do not exist in isolation, as comorbidities can further complicate treatment and recovery processes.

Rising Healthcare Costs

The trend towards increasing healthcare costs continues, driven largely by the prevalence of specialty treatments and advanced gene therapies. Notable statistics include a 43% increase in spending on liver disease treatment in 2025, with an average cost per patient reaching $230,000. Furthermore, the most expensive treatment identified in the report is Elevidys, a gene therapy for Duchenne muscular dystrophy, averaging $3.6 million per patient—a stark representation of how specialty medications are reshaping the financial landscape of healthcare.

The Role of GLP-1 Medications

Obesity and diabetes are linked to many high-cost health conditions, allowing for proactive measures via broader coverage of GLP-1s (glucagon-like peptide-1 receptor agonists). While the individual costs of GLP-1s remain relatively low, claims associated with these medications saw an increase of 24% last year. By broadening access, employers can mitigate the risk of severe health issues that lead to high-dollar claims in the long run, potentially easing overall costs for organizations.

Impact of Health Services

Integrative healthcare programs that focus on preventative measures significantly enhance health outcomes and can effectively reduce medical expenses. Disorders such as osteoarthritis, which is frequently seen among patients with chronic kidney disease, underscore the need for simultaneous healthcare approaches. Research cited in the Sun Life report indicates that osteoarthritis serves not only as a significant health concern but may also predict chronic kidney disease.

The most common cancer diagnosis among working-age individuals remains solid tumors, emphasizing the importance of acknowledging and acting upon prevalent health issues accurately.

Sun Life's Health Solutions

To combat the challenges posed by high-cost claims, Sun Life has initiated several health and risk management services aimed at addressing the factors driving these expenses. These include:

• - Orthopedic/MSK Health Support: Collaborating with companies like Hinge Health.
• - Expert Review Programs: Engaging clinical experts to assess cost-reduction opportunities.
• - Healthcare Navigation Services: Through Health Navigator, assisting individuals in receiving timely and appropriate care.
• - Expert Cancer Review: Providing patients with second opinions from top oncologists to guarantee the right diagnosis and treatment plans.

By leveraging their expertise as a leading stop-loss provider, Sun Life aims to shed light on healthcare trends and implications, fostering a better understanding of the complex interplay between various health conditions and the financial burdens they inflict on both individuals and employers.
i] Explore more about Sun Life and their innovative health solutions by visiting [Sun Life U.S. for comprehensive insights into stop-loss insurance and health-and-risk management strategies.